Dr. Gregory Parada, MD

Dr. Parada practices at Select Physical Therapy - Carlsbad in Carlsbad, California.

Dr. Parada's NPI, 1003037037, was assigned on May 1, 2007. Dr. Parada graduated from University of Washington School of Medicine in 2006. Dr. Parada holds Washington license 61-2555.

Dr. Parada's primary practice is Select Physical Therapy - Carlsbad, at 6183 Paseo Del Norte Ste 250, Carlsbad, CA 92011. The practice phone is (717) 972-1100.

Dr. Parada's primary practice is Select Physical Therapy - Carlsbad in Carlsbad, California. Dr. Parada is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Parada to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parada practices, 3 sites in all. Vendor and product names are available with a free account.

Preventive medicine is Dr. Parada's primary specialty in the NPI Registry, under taxonomy code 2083A0300X. The record also lists addiction medicine. Dr. Parada is board certified in addiction medicine by the American Board of Emergency Medicine. Dr. Parada is licensed in Washington.

CMS data shows 45 Medicare services from Dr. Parada across 1 procedure code in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $3,204 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Parada in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have alcohol and drug use disorders, and 63% have anxiety. 31% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parada's median patient age at 62, with 42% women.

In 2024, Dr. Parada wrote 281 Medicare Part D claims for 56 patients. 93% of them were for generic drugs. CMS names the drug for 182 of them, across 3 drugs with 11 or more claims each, at $17,569 in total drug cost. In 2023, CMS named 203 claims across 4 drugs.

Dr. Parada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parada as offering telehealth.

Dmand AI links Dr. Parada to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 2 general payments to Dr. Parada from 2 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 84% of the total. Alkermes, Inc. paid the most, $150.

Dr. Parada graduated from University of Washington School of Medicine in 2006.